The enduring education will highlight improving clinicians knowledge and competence in the early recognition, diagnosis, and treatment of biliary tract cancer (BTC), including multidisciplinary approaches to enhance patient quality of life on an immune checkpoint inhibitor (ICI) plus chemotherapy combination. As a result of this, learners will be better to: 1. Identify best practices for early recognition of patients with biliary tract cancer (BTC) to optimize diagnosis 2. Discuss multidisciplinary strategies to address key diagnostic challenges in advanced BTC 3. Describe the clinical profiles of immune checkpoint inhibitor (ICI) plus chemotherapy combinations for the first-line treatment for advanced BTC 4. Outline multidisciplinary approaches to enhance care of patients with advanced BTC on an ICI plus chemotherapy combination
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/QXN
- Start Date: 2024-12-09 06:00:00
- End Date: 2024-12-09 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 78110.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all